Nanovibronix Stock Predictions

Healthcare > Medical - Devices

Buy NAOV

*Your capital is at risk

$4.02

+0 (+0%)

At Close: Mar 13, 2026

Currently predicting for Fri, 5 Jun 2026

NAOV Prediction Chart

NAOV Predictions History

Latest community submissions for NAOV.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Michelle Dumaine @MichelleDumaine.124510	Jan 16, 2025	Bullish	$0.520	X	—	0
godivaoneandonly.255699	Sep 7, 2021	Bullish	$2.46	X	—	1
RamboRex3000 Pro	Sep 7, 2021	$2.33 -99.57%	$2.46	X	94.72%	1
JS Pro	Sep 7, 2021	$2.20 -99.59%	$2.46	V	89.43%	0
Sabin.Simionov	Sep 7, 2021	Bullish	$2.46	X	—	0
Claes @Claes.9484	Sep 7, 2021	Bullish	$2.46	X	—	0
JS Pro	Sep 3, 2021	$2.47 -99.51%	$2.29	V	92.14%	1
JS Pro	Aug 25, 2021	$2.98 -99.56%	$3.08	X	96.75%	1
RamboRex3000 Pro	Aug 24, 2021	$2.74 -99.57%	$2.92	V	93.84%	0
JS Pro	Aug 24, 2021	$2.79 -99.57%	$2.92	X	95.55%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NAOV with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT NANOVIBRONIX, INC

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by